Healthcare · Diagnostics & Research
Sai Life Sciences Ltd.
SAILIFE
Financials as of(≥90-day lag, SEBI compliant)
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
NSE: SAILIFEOfficial website ↗
Key metrics
Market Cap
₹21,157 cr
P/E Ratio
63.31x
P/B Ratio
9.94x
ROE
7.99%
ROCE
12.25%
Debt / Equity
0.17x
Net Margin
10.25%
Dividend Yield
—
EPS
₹8.61
Period
FY2025
Shareholding pattern
As of LatestPromoter: 38.09%FII: 41.49%Public: 20.42%
Deep-dive pages
Educational content — not investment adviceThis page presents publicly available information about Sai Life Sciences Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.